Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/16974
Title: Nanoparticles of biodegradable polymers for delivery of therapeutic agents and diagnostic sensitizers to cross the blood brain barrier (BBB) for chemotherapy and MRI of the brain
Authors: CHEN LIRONG
Keywords: Chemotherapy, Brain tumor, Medical imaging, MRI, Nanotechnology
Issue Date: 23-Nov-2005
Source: CHEN LIRONG (2005-11-23). Nanoparticles of biodegradable polymers for delivery of therapeutic agents and diagnostic sensitizers to cross the blood brain barrier (BBB) for chemotherapy and MRI of the brain. ScholarBank@NUS Repository.
Abstract: This project is to develop nanoparticles of biodegradable polymers for delivery of therapeutic agents or imaging sensitizers to cross the blood brain barrier (BBB). Paclitaxel-loaded PLGA nanoparticles were prepared by a modified single emulsion method. Nanoparticles are characterized by laser light scattering for size and size distribution, SEM and AFM for morphology, HPLC for drug encapsulation efficiency and in vitro drug release kinetics. Madin-Darby Canine Kidney (MDCK) cell line is used to simulate the BBB for in vitro cellular uptake experiment. It is found that employing nanoparticles for drug delivery across the BBB seem feasible and the particle size and surface coating play key roles. Gadolinium-DTPA loaded nanoparticles of PLGA and PLA-PEG are prepared by the nanoprecipitation method for in vivo MRI evaluation. < 100nm PLA-PEG nanoparticles and < 200nm PLGA nanoparticles are manufactured with 0.92-1.74% loading of Gd-DTPA. In vivo MRI is still under development.
URI: http://scholarbank.nus.edu.sg/handle/10635/16974
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
chen lirongs thesis.pdf2 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

343
checked on Dec 11, 2017

Download(s)

576
checked on Dec 11, 2017

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.